Logo 1 Logo 2

Clinical Trial Details

Trial ID: L4482
Source ID: NCT00060918
Associated Drug: Carvedilol
Title: Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Hypertension
Interventions: DRUG: carvedilol|DRUG: metoprolol
Outcome Measures: Primary: Change from baseline in HbA1c at 5 months, 5 months | Secondary: Blood pressure at 3 and 5 months. Body weight at 3 and 5 months. Lab values (glucose, insulin, triglycerides, cholesterol, and albumin:creatinine ratio) at 3 and 5 months., 5 months
Sponsor/Collaborators: Sponsor: GlaxoSmithKline
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 1210
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Start Date: 2001-06
Completion Date: 2004-04
Results First Posted:
Last Update Posted: 2015-04-15
Locations: GSK Investigational Site, Glendale, Arizona, 85306, United States|GSK Investigational Site, Phoenix, Arizona, 85016, United States|GSK Investigational Site, Phoenix, Arizona, 85050, United States|GSK Investigational Site, Tucson, Arizona, 85724, United States|GSK Investigational Site, Burlingame, California, 94010, United States|GSK Investigational Site, Concord, California, 94520, United States|GSK Investigational Site, Encinitas, California, 92024, United States|GSK Investigational Site, Hemet, California, 92543, United States|GSK Investigational Site, Long Beach, California, 90806, United States|GSK Investigational Site, Orange, California, 92868, United States|GSK Investigational Site, Pasadena, California, 91105, United States|GSK Investigational Site, Riverside, California, 92501, United States|GSK Investigational Site, San Diego, California, 92102, United States|GSK Investigational Site, San Luis Obispo, California, 93405, United States|GSK Investigational Site, Spring Valley, California, 91978, United States|GSK Investigational Site, Aurora, Colorado, 80045, United States|GSK Investigational Site, Denver, Colorado, 80220, United States|GSK Investigational Site, Golden, Colorado, 80401, United States|GSK Investigational Site, Panama City, Florida, 32401, United States|GSK Investigational Site, St. Petersburg, Florida, 33701, United States|GSK Investigational Site, Honolulu, Hawaii, 96813, United States|GSK Investigational Site, Idaho Falls, Idaho, 83404, United States|GSK Investigational Site, Chicago, Illinois, 60612, United States|GSK Investigational Site, O'Fallon, Illinois, 62269, United States|GSK Investigational Site, Elkhart, Indiana, 46515, United States|GSK Investigational Site, Indianapolis, Indiana, 46260, United States|GSK Investigational Site, Iowa City, Iowa, 52242, United States|GSK Investigational Site, Kalamazoo, Michigan, 49009, United States|GSK Investigational Site, Oak Park, Michigan, 48237, United States|GSK Investigational Site, Minneapolis, Minnesota, 55417, United States|GSK Investigational Site, Kansas City, Missouri, 64106, United States|GSK Investigational Site, Kansas City, Missouri, 64111, United States|GSK Investigational Site, St. Louis, Missouri, 63110, United States|GSK Investigational Site, St. Louis, Missouri, 63128, United States|GSK Investigational Site, Las Vegas, Nevada, 89103, United States|GSK Investigational Site, Albuquerque, New Mexico, 87131, United States|GSK Investigational Site, Oklahoma City, Oklahoma, 73112, United States|GSK Investigational Site, Bend, Oregon, 97701, United States|GSK Investigational Site, Oregon City, Oregon, 97045, United States|GSK Investigational Site, Dallas, Texas, 75390, United States|GSK Investigational Site, Fort Worth, Texas, 76104, United States|GSK Investigational Site, Georgetown, Texas, 78626, United States|GSK Investigational Site, Midland, Texas, 79705, United States|GSK Investigational Site, San Antonio, Texas, 78259, United States|GSK Investigational Site, San Antonio, Texas, 78299, United States|GSK Investigational Site, The Colony, Texas, 75056, United States|GSK Investigational Site, Ogden, Utah, 84401, United States|GSK Investigational Site, Renton, Washington, 98055, United States|GSK Investigational Site, Madison, Wisconsin, 53792, United States|GSK Investigational Site, Milwaukee, Wisconsin, 53151, United States
URL: https://clinicaltrials.gov/show/NCT00060918

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D337 Carvedilol small molecule DB01136 Details